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Sestrin2 is induced by glucose 
starvation via the unfolded protein 
response and protects cells from 
non-canonical necroptotic cell 
death
Boxiao Ding1,*, Anita Parmigiani1,*, Ajit S. Divakaruni3, Kellie Archer2, Anne N. Murphy3 & 
Andrei V. Budanov1
Sestrin2 is a member of a family of stress responsive proteins, which controls cell viability via 
antioxidant activity and regulation of the mammalian target of rapamycin protein kinase (mTOR). 
Sestrin2 is induced by different stress insults, which diminish ATP production and induce energetic 
stress in the cells. Glucose is a critical substrate for ATP production utilized via glycolysis and 
mitochondrial respiration as well as for glycosylation of newly synthesized proteins in the endoplasmic 
reticulum (ER) and Golgi. Thus, glucose starvation causes both energy deficiency and activation of ER 
stress followed by the unfolding protein response (UPR). Here, we show that UPR induces Sestrin2 
via ATF4 and NRF2 transcription factors and demonstrate that Sestrin2 protects cells from glucose 
starvation-induced cell death. Sestrin2 inactivation sensitizes cells to necroptotic cell death that 
is associated with a decline in ATP levels and can be suppressed by Necrostatin 7. We propose that 
Sestrin2 protects cells from glucose starvation-induced cell death via regulation of mitochondrial 
homeostasis.
Eukaryotic organisms rely on glucose as a critical source for ATP production when metabolized via glycolysis 
and mitochondrial respiration. Glucose is also a substrate for glycosylation, a post-translational modification 
that occurs primarily in the endoplasmic reticulum (ER)1. Glucose starvation activates at least two mechanisms 
of the stress response: one senses energy availability via activation of 5′ -AMP-activated protein kinase (AMPK)2, 
and another is activated through accumulation of unfolded and unprocessed proteins in the ER and induction 
of ER stress followed by a program called the unfolded protein response (UPR)3,4. The UPR activates three path-
ways mediated by: protein kinase (PKR)-like ER kinase (PERK1), activating transcription factor 6 (ATF6) and 
inositol-requiring enzyme 1 (IRE1)3,5. PERK1 directly phosphorylates and inhibits eukaryotic translation initia-
tion factor 2 alpha (eIF2α ), causing suppression of global protein synthesis; however, it also re-directs the trans-
lational machinery toward translation of specific mRNAs involved in the UPR4,5.
The major function of the PERK1-eIF2α pathway is to activate transcription factor 4 (ATF4)3, which is 
induced via a translation-dependent mechanism. ATF4 is a master regulator of numerous genes involved 
in the UPR6. Some of these genes, such as transcription factor CHOP, induce cell death, while others protect 
cell viability through suppression of cell death machinery and relief of ER stress, or by regulating metabolism4. 
Another important target of PERK is the master regulator of antioxidant response and metabolism Nuclear 
factor (erythroid-derived 2)-like 2 (NRF2)7. Under non-stressed conditions NRF2 is constantly bound to its 
partner Kelch like-ECH-associated protein 1 (Keap1) which retains NRF2 in the cytoplasm and stimulates its 
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degradation. Under stress conditions, PERK directly phosphorylates NRF2 leading to its dissociation from Keap1 
and translocation to the nucleus where it activates the transcription of its target genes via recognition of antioxi-
dant responsive elements (ARE)8.
We have identified and characterized the Sestrin (SESN) family of stress-responsive genes9,10 composed 
of SESN1, SESN2 and SESN3 genes in mammals while only one Sestrin ortholog has been found in inverte-
brates10. Sestrins are activated by multiple insults including oxidative stress, DNA damage, hypoxia, growth factor 
depletion and ER stress11. We demonstrated that protein products of Sestrin genes work as antioxidant proteins 
suppressing oxidative DNA damage and mutagenesis12,13. Furthermore, Sestrins also inhibit mammalian tar-
get of rapamycin (mTOR) complex 1 (mTORC1) kinase, a critical regulator of cell growth and metabolism14–16. 
Sestrins inhibit mTORC1 in a manner dependent on AMPK and tuberous sclerosis complex (TSC), which, in 
turn, inhibits the small GTPase Rheb, a critical activator of mTORC114,15,17–19. We and others have also described 
a parallel mechanism of mTORC1 inhibition by Sestrins mediated by small Rag GTPases20–22. Active forms of 
RagA/B:RagC/D heterodimers bring mTORC1 to the lysosomes where it interacts with Rheb23. The RagA/B 
activity is inhibited by its GTPase activated protein (GAP) - GATOR1 protein complex, which is in turn inhibited 
by GATOR2 protein complex. Sestrins interact with GATOR2 and inhibit mTORC1 lysosomal localization20,21.
In our previous publications, we demonstrated that SESN2 is activated in response to some metabolic stress 
factors and is involved in the regulation of cell viability9,24; however, the precise role of SESN2 in the regulation 
of cell death is not well established. Here we show that glucose starvation stimulates SESN2 via induction of ER 
stress and that SESN2 protects cells from necrotic cell death through the support of cell metabolism, ATP produc-
tion and mitochondrial function.
Results
SESN2 is activated in response to energy stress in a manner similar to the UPR induction. 
Different inducers of energy stress such as an inhibitor of glucose metabolism - 2-deoxyglucose (2DG), an inhib-
itor of complex I of the mitochondrial electron transport chain - rotenone and hypoxia stimulate expression of 
SESN29,20,24. Thus, we theorized that any type of stress associated with diminished ATP may stimulate SESN2 
expression, and that AMP itself may trigger SESN2 induction. To test this possibility, we treated cells with 2DG, 
rotenone, glucose-free medium with and without sodium pyruvate, or Aicar (an AMP analog), and compared 
the effects of each of these treatments on the activation of Sestrins as measured by immunoblotting and quanti-
tative real time PCR (qPCR) in H1299 cells and in immortalized mouse embryonic fibroblasts (MEF). Glucose 
withdrawal, 2DG and rotenone activated SESN2; however, Aicar treatment had no effect on SESN2 induction 
(Fig. 1a–c). Analysis of AMPK activation by examination of phosphorylation of AMPK and its target ACC 
showed that all treatments including Aicar strongly activated AMPK and inhibited mTORC1-dependent phos-
phorylation of S6, indicating that regulation of AMPK-mTORC1 pathway is probably not the trigger of SESN2 
activation under conditions of energy deficiency. We also observed that SESN2 was the only Sestrin family mem-
ber to be activated in our experimental conditions, indicating that SESN2 is the major responder to energy stress 
among Sestrins (Fig. 1a,b).
Proper protein folding in the ER requires ATP. Therefore, low ATP levels might trigger ER stress and UPR 
through accumulation of misfolded proteins. We observed that all treatments except Aicar promoted accumu-
lation of ER stress inducible transcription factors ATF4 and NRF2 (Fig. 1d). The magnitude of UPR induction 
varied in different treatment conditions, and we observed the strongest activation of the hallmarks of ER stress 
such as Bip, CHOP and phosphorylation of eIF2α in the glucose-starved cells (Fig. 1d). Therefore, in subsequent 
studies we focused on the regulation of SESN2 by glucose starvation as the type of energetic stress. To confirm 
that activation of SESN2 correlates with induction of ER stress, we analyzed expression levels of SESN2 at differ-
ent time points after glucose withdrawal and observed a clear correlation with the induction of SESN2, ATF4 and 
NRF2 as determined by immunoblotting and qPCR (Fig. 1e,f).
Glucose starvation activates SESN2 via a mechanism dependent on ATF4 and NRF2, but not 
p53. To study the role of ATF4 and NRF2 in the activation of SESN2 in response to glucose starvation, we 
silenced each of these proteins by shRNA lentivirus, treated cells with glucose-free medium and analyzed protein 
and mRNA expression. Silencing either NRF2 or ATF4 prevented the activation of SESN2 upon glucose starva-
tion (Fig. 2a,b). To study whether glucose starvation can stimulate binding of NRF2 to NRF2-binding element 
in position − 55025 and ATF4 to its cognate responsive elements in proximal (− 138) and distant (− 16 kB) parts 
of the SESN2 promoter26, we performed chromatin immunoprecipitation assay (CHIP). We observed a strong 
interaction of NRF2 and ATF4 with the SESN2 promoter in response to glucose starvation (Fig. 2c). Another 
transcription factor that plays a major role in the regulation of SESN2 is p53, and energy stress is known to trigger 
p53 activation9,27. As H1299 cells do not express p53, we utilized H1299-tta cells with doxycycline-dependent 
p53 regulation (H1299-tet-off-p53) in order to analyze the potential contribution of p53 in SESN2 induction by 
glucose withdrawal9. As shown in Fig. 2d, glucose starvation, as well as rotenone treatment, induced SESN2 in a 
similar manner in the p53-positive and p53-negative cells. In a complementary experiment we treated Trp53+/+ 
and Trp3−/− MEF with glucose-free medium and rotenone and observed a negligible effect of p53 on mouse Sesn2 
activation (Fig. 2e). Taken together, these data indicate that the transcription factors ATF4 and NRF2, but not 
p53, are responsible for SESN2 induction in glucose-starved cells.
SESN2 is not a critical regulator of ER stress and AMPK activation in response to glucose star-
vation. As previously reported, SESN2 is a potential regulator of the AMPK-mTORC1 pathway and ER stress 
response14,28,29. To study whether SESN2 plays a role in regulation of ACC phosphorylation or expression of ER 
stress-induced proteins, indicators of the severity of ER stress, we silenced SESN2 in H1299 cells by shRNA lenti-
virus and analyzed ACC phosphorylation and activation of ER stress proteins by immunoblotting. We observed 
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similar levels of ACC phosphorylation and activation of Bip, CHOP, IF2α , ATF4, and NRF2 in glucose-starved 
control and SESN2-silenced cells (Fig. 3a). We also analyzed the kinetics of activation of UPR factors and phos-
phorylation of AMPK, ACC and mTORC1 targets S6 and 4EBP1 in the control cells and in the cells, where SESN2 
was inactivated by a CRISPR construct. No significant difference was found in the activation of NRF2, ATF4, Bip, 
AMPK, and ACC or in the inhibition of S6 and 4EBP1 phosphorylation (Fig. 3b). Additionally, we measured 
accumulation of the pro-autophagic LC3-II protein and the expression of autophagic p62 protein and did not 
observe any noticeable difference. This indicates that SESN2 does not play an important role in regulation of the 
Figure 1. SESN2 is activated by glucose starvation in manner correlated with the induction of the 
unfolded protein response. (a,b) Energetic stress, but not AICAR treatment stimulates SESN2 expression. 
H1299 cells were treated with glucose-free medium in the presence or absence of pyruvate, rotenone (20 μM), 
2-deoxyglucose (2DG) (2.5 mM) or Aicar (1 mM) for 12 hr. The phosphorylation of the components of the 
AMPK-mTORC1 pathway and the expression of Sestrin family members were analyzed by immunoblotting 
with the indicated antibodies (a) or quantitative real time PCR (qPCR) (b). The data represent a mean of three 
independent experiments ± S.D. (b) statistical analysis: one-way ANOVA followed by comparisons to the 
control group with Bonferroni correction (adjusted α = 0.05/5 = 0.01, **P < 0.01). (c) Energetic stress, but not 
Aicar treatment, stimulates Sesn2 expression in MEF. MEF were treated and analyzed as in (a). (d–f) Activation 
of SESN2 correlates with activation of the UPR proteins. H1299 cells were incubated with glucose-free medium 
for different time intervals and expression of SESN2 and the UPR proteins and phosphorylation of components 
of the AMPK-mTORC1 pathway were analyzed by immunoblotting (d,e) and qPCR (f).
www.nature.com/scientificreports/
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UPR or AMPK-mTORC1 under glucose starvation (Fig. 3b). We also considered the possibility that SESN2 can 
provide relief from ER stress when cells are re-supplied with glucose. Thus, we analyzed NRF2 and ATF4 protein 
levels at different time points after the cells were re-fed with glucose and observed that both proteins were down-
regulated with similar kinetics in both SESN2-proficient and SESN2-deficient cells (Fig. 3c).
Figure 2. Glucose starvation activates SESN2 via NRF2- and ATF4- dependent but via p53-independent 
mechanism. (a,b) Silencing of either NRF2 or ATF4 inhibits SESN2 activation by glucose withdrawal. H1299 
cells were infected with lentiviral vectors expressing shNRF2, shATF4 or control shLuciferase (shLuc). The cells 
were incubated with glucose-free medium for 12 hr and expression of the corresponding proteins was examined 
by immunoblotting (a) and qPCR (b). The data represent a mean of three independent experiments ± S.D. 
Data in (b) were analyzed with two-way ANOVA followed by linear contrasts with Bonferroni correction 
(adjusted α = 0.05/9 = 0.0056, **P < 0.0056). (c) NRF2 and ATF4 bind corresponding NRF2- and ATF4-
responsive elements in the SESN2 promoter. Cells were incubated in glucose-free medium for 4 and 12 hours 
and NRF2 and ATF4 binding to the corresponding promoter elements were analyzed by CHIP assay (dist.-
distal and prox.-proximal ATF4-responsive elements in SESN2 promoter). The data represent a mean of three 
independent experiments ± S.D. (c) statistical analysis: two-way ANOVA followed by linear contrasts with 
Bonferroni correction (adjusted α = 0.05/6 = 0.0083, **P < 0.0083). (d,e) p53 does not play a significant role in 
SESN2 regulation by energetic stress. (c) H1299 cells with doxycycline-inducible expression of p53 were treated 
with glucose-free medium or rotenone (20 μM) and the expression of the indicated proteins was analyzed by 
immunoblotting. (d) Trp53+/+ and Trp53−/− mouse embryonic fibroblasts were incubated in glucose-free 
medium or with rotenone (20 μM) for 12 hr and the expression of the corresponding proteins was analyzed by 
immunoblotting.
www.nature.com/scientificreports/
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Sesn2 protects from cell death induced by glucose starvation. Glucose is required for cellular 
homeostasis, and prolonged glucose starvation induces cell death30. Since SESN2 plays an important role in 
the regulation of cell viability under stress9, we investigated its role in regulating cell viability during glucose 
withdrawal. We treated immortalized Sesn2+/+ and Sesn2−/− MEF with glucose-free medium and analyzed cell 
death by AnnexinV/-PI staining. Following glucose deprivation, the loss in viability was more than doubled at 
24 hr in Sesn2-deficient MEF compared to their WT counterparts (Fig. 4a–c). Interestingly, most of cells were 
AnnexinV+PI+ or PI+, while we observed only a negligible fraction of AnnexinV+PI− cells between Sesn2+/+ and 
Sesn2−/− cell types, even at early time points after glucose withdrawal. This suggests that most of the cells died 
via necrosis/necroptosis or quickly progressed from apoptosis to necrosis (Fig. 4b). To validate the role of Sesn2 
in protection against glucose starvation-induced cell death we re-constituted Sesn2−/− MEF with a retrovirus 
construct expressing Sesn2 (Fig. 4d) and analyzed cell death after glucose withdrawal. We observed that Sesn2 
re-constitution strongly suppressed cell death in the Sesn2-deficient MEF (Fig. 4d,e). To study whether Sesn2 
has some protective effects in cancer cells, we incubated lung adenocarcinoma SESN2-deficient H1299 cells or 
SESN2-silenced H460 cells and their control counterparts with glucose-free medium and found that in both cell 
lines SESN2 had a significant protective effect against cell death (Fig. 4f,g).
Figure 3. SESN2 does not play a role in regulation of the AMPK-mTORC1 pathway and UPR during 
glucose starvation. (a) Silencing of SESN2 by shSESN2 lentivirus does not affect the magnitude of ACC 
phosphorylation and UPR activation. SESN2-silenced and control shLuc-expressed H1299 cells were incubated 
with glucose-free medium and ACC phosphorylation and activation of the UPR proteins were assessed by 
immunoblotting. (b) SESN2 does not affect the kinetics of UPR activation and regulation of the AMPK-
mTORC1 pathway by glucose starvation. sgSESN2- or sgCon.- H1299 cells were incubated with glucose-free 
medium for different time intervals and the phosphorylation and expression of the corresponding proteins were 
analyzed by immunoblotting. (c) SESN2 does not affect UPR release following re-feeding of cells with glucose. 
Cells as in (b) were incubated for 12 hr with glucose-free medium and re-supplied with glucose for different 
time intervals. The expression of corresponding proteins was analyzed by immunoblotting.
www.nature.com/scientificreports/
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Figure 4. Sesn2 protects cells against cell death induced by glucose withdrawal. (a–c) Sesn2−/− cells are more 
susceptible to cell death in response to glucose starvation than their Sesn2+/+ counterparts. (a) Phase-contrast 
microscopy of Sesn2+/+and Sesn2−/− MEF incubated with control and glucose-free medium for 24 hr. (b) Sesn2+/+ 
and Sesn2−/− MEF were incubated with glucose-free medium for 24 hr and cell death was determined by 
Annexin V/PI staining followed by flow cytometry analysis. (c) Sesn2+/+ and Sesn2−/− MEF were incubated 
with glucose-free medium for different time intervals and cell death was determined by PI staining followed by 
flow cytometry analysis. The data represent a mean of three independent experiments ± S.D. Two-way ANOVA 
followed by linear contrasts with Bonferroni correction (adjusted α = 0.05/4 = 0.0125, **P < 0.0125). (d,e) Re-
constitution of Sesn2 in Sesn2-deficient cells suppresses cell death induced by glucose starvation. (d) Sesn2−/− 
MEF were infected with retroviral pBabe-hygro construct expressing Sesn2 and selected with hygromycin. 
Sesn2 expression was analyzed by immunoblotting. (e) Cells from (d) were incubated with glucose-free 
medium and analyzed by PI staining as in (b). The data represent a mean of three independent experiments ± S.D. 
Two-way ANOVA followed by linear contrasts with Bonferroni correction (adjusted α = 0.05/6 = 0.0083, 
**P < 0.0083). (f) sgCon. and sgSESN2 H1299 cells were treated with glucose-free medium and analyzed as in (b).  
The data represent a mean of three independent experiments ± S.D. Two-way ANOVA followed by linear 
contrasts with Bonferroni correction (adjusted α = 0.05/3 = 0.0167, **P < 0.0167). (g) H460 cells expressed 
shSESN2 or control shLuc constructs were incubated with glucose-free medium for 24 hr and analyzed as in (b).
www.nature.com/scientificreports/
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Sesn2 protects against glucose starvation-induced cell death not through regulation of 
caspase-dependent apoptosis, ROS or mTORC1. As it was reported that Sesn2 protects from apop-
tosis under some stress conditions24,28, we analyzed the cleavage of caspase 3 and PARP, the markers of apoptotic 
cell death, after 24 hr of incubation with glucose-free medium. We observed no significant difference in cleavage 
of both proteins in Sesn2+/+ and Sesn2−/− MEF indicating that the mode of cell death and protection by Sesn2 in 
response to glucose withdrawal is not through apoptosis (Fig. 5a). We also did not see any difference in regulation 
of CHOP, the major activator of apoptosis in response to ER stress31. As demonstrated previously Sesn2 can pro-
tect against cell death via regulation of the AMPK-mTORC1 pathway or suppression of reactive oxygen species32. 
Figure 5. Sesn2 suppresses cell death induced by glucose starvation via a mechanism independent on 
caspase activation, ROS or mTORC1. (a) Sesn2 deficiency does not affect caspase activation and regulation of 
the AMPK-mTORC1 pathway by glucose starvation. Sesn2+/+ and Sesn2−/− MEF were incubated with control 
high-glucose (gluc+ ) or glucose-free (gluc− ) medium for 24 hr and the expression and phosphorylation of 
the corresponding proteins were analyzed by immunoblotting with the indicated antibodies. (b,c) Sesn2-
deficient cells have higher levels of ROS in normal and glucose-free medium. (b) Sesn2+/+ and Sesn2−/− 
MEF were incubated with glucose-free medium for different time intervals and the levels of ROS were 
determined by DCFDA staining followed by flow cytometry. The data represent a mean of three independent 
experiments ± S.D. Two-way ANOVA followed by linear contrasts with Bonferroni correction (adjusted 
α = 0.05/5 = 0.01, **P < 0.01). (c) sgCon. and sgSESN2 H1299 cells were incubated with glucose-free medium 
and analyzed as in (b). Two-way ANOVA with replication, followed by Bonferroni post-test (*p < 0.05, 
**p < 0.01). (d) Treatment with antioxidant, pan-caspase inhibitor or mTORC1 inhibitor does not affect cell 
death induced by glucose starvation. Sesn2+/+ and Sesn2−/− MEF were treated with antioxidant N-acethyl-
cysteine, NAC (5 mM), inhibitor of caspases, Boc-D-FMK (20 μM), or mTORC1 inhibitor, rapamycin (10 nM), 
for 24 hr and cell death levels were determined by PI staining followed by flow cytometry. The data represent a 
mean of three independent experiments ± S.D. Two-way ANOVA followed by linear contrasts with Bonferroni 
correction (adjusted α = 0.05/10 = 0.005, **P < 0.005).
www.nature.com/scientificreports/
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To study whether Sesn2 regulates AMPK and mTORC1 in MEF in response to glucose starvation, we analyzed 
phosphorylation of AMPK, S6 and 4EBP1 and found that glucose starvation stimulates AMPK phosphorylation 
and inhibits S6 and 4EBP1 phosphorylation in a Sesn2-independent manner (Fig. 5a). It was also reported previ-
ously that Sesn2 might stimulate AKT protein kinase that inhibits cell death. To address this possibility, we ana-
lyzed AKT-dependent phosphorylation of GSK3α and TSC2 and did not find any differences in phosphorylation 
of these proteins between Sesn2+/+ and Sesn2−/− MEF (Fig. 5a). We also analyzed the intracellular levels of ROS 
by DCF-DA staining in Sesn2+/+ and Sesn2−/− MEF and in SESN2-proficient and SESN2-deficient H1299 cells 
incubated in glucose-free medium. As reported previously12,13, Sesn2-deficient cells showed higher levels of ROS 
as compared to the Sesn2-expressing controls at baseline. Glucose starvation led to accumulation of ROS in both 
Sesn2-proficient and Sesn2-deficient cells, although this phenomenon was more dramatic in the Sesn2-deficient 
cells (Fig. 5b,c). Treatment of glucose-starved cells with the ROS scavenger N-acetyl-cysteine (NAC) reduced ROS 
levels in both Sesn2+/+ and Sesn2−/− MEF, but the difference in ROS levels between the Sesn2+/+ and Sesn2−/− cells 
remained significant (Fig. 5b). To study whether Sesn2-controlled cell death in response to glucose starvation 
mediated by regulation of caspase activation, mTORC1 activity or ROS production, we incubated Sesn2+/+ and 
Sesn2−/− MEF in glucose-free medium in the presence of the pan-caspase inhibitor, Boc-D-FMK, the mTORC1 
inhibitor, rapamycin, or ROS scavenger, NAC. Cell death analysis revealed no difference between cells treated 
with glucose-free medium in the presence or absence of any of these inhibitors (Fig. 5d). The difference between 
Sesn2+/+ and Sesn2−/− cells was preserved in all treatments, indicating that Sesn2 does not suppress cell death 
induced by glucose starvation by regulating caspases, mTORC1 or ROS.
Sesn2 selectively protects cells from glucose starvation-induced cell death via a non-canonical 
necroptotic pathway. Although apoptosis is the major form of physiological cell death, other types of cell 
death such as autophagic cell death, necroptosis and ferroptosis have been also reported33,34. To analyze whether 
glucose starvation induces cell death via any of these mechanisms and to determine the impact of Sesn2 on these 
processes, we incubated Sesn2+/+ and Sesn2−/− MEF with glucose-free medium in the presence of autophagy 
inhibitors 3-Methyladenine (3-MA) or Chloroquine (CQ), an inhibitor of classical RIP1-dependent necropto-
sis - Necrostatin 135, or an inhibitor of ferroptosis - Ferrostatin 136. We observed no difference in cell death, 
whether cells were incubated in glucose-free medium in the presence or absence of any of these inhibitors, and 
the difference in cell death between Sesn2+/+ and Sesn2−/− MEF was preserved in all of these experimental con-
ditions (Fig. 6a). This indicates that in our experimental setting, Sesn2 does not protect cells from cell death 
either through regulation of autophagy, through classical RIP1-dependent necroptosis, or through ferroptosis. 
Interestingly, treatment with TUDCA, which works as an ER chaperone and mitigates some aspects of ER stress37, 
strongly inhibited cell death in both Sesn2+/+ and Sesn2−/− cells (Fig. 6a), indicating that this type of cell death is 
relevant to the induction of ER stress.
In order to examine potential alternative forms of cell death inhibited by Sesn2, we treated cells with 
Necrostatin 7, which inhibits a form of necroptosis that proceeds via a RIP1-independent mechanism38. We 
observed that while Necrostatin 7 had no effect on cell death in control cells, it strongly inhibited cell death in 
Sesn2−/− MEF, thus indicating that Sesn2 selectively protects from a non-canonical form of necroptosis (Fig. 6b).
Sesn2 inhibits glucose starvation-induced cell death via preservation of cellular energy metab-
olism. Necrosis/necroptosis is often associated with mitochondrial dysfunction and a drop in ATP levels. 
Because Sesn2 can regulate ATP production24, we studied whether Sesn2 can support ATP production in cells 
cultured in glucose-free medium. We analyzed ATP levels in Sesn2+/+ and Sesn2−/− MEF and found that a drop in 
ATP levels was much faster in Sesn2−/− cells as compared to Sesn2+/+ controls (Fig. 7a).
As Sesn2 clearly protects from ATP depletion associated with glucose deprivation, we used the Seahorse 
platform to assess the effect of Sesn2 expression on cellular energy metabolism and mitochondrial respiration. 
Assaying intact MEF, we discovered that the basal rate of extracellular acidification, expressed as the proton 
production rate (Fig. 7b), was significantly lower in Sesn2-deficient cells compared to control. The rate of extra-
cellular acidification is primarily a function of glycolytic lactate production, along with contribution by TCA 
cycle generation of CO2 that produces carbonic acid39. Further, the basal (endogenous) rates of respiration were 
also significantly lower in the Sesn2−/− cells (Fig. 7c). A significant difference in respiratory rate persisted after 
the addition of the respiratory uncoupler, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) 
(Fig. 7d). FCCP stimulates the maximal rate of mitochondrial respiration indicating the respiratory capacity of 
mitochondria. These data imply a significant decrease in glycolytic and mitochondrial function in the Sesn2−/− 
MEF. To study whether the effect of Sesn2 on mitochondrial function is on a particular oxidative pathway within 
mitochondria, we measured rates of State 3 (ADP-stimulated) respiration in permeabilized fibroblasts. Rates 
of respiration on pyruvate/malate, glutamate/malate, palmitoyl carnitine/malate, or succinate/rotenone were 
significantly and proportionately diminished in Sesn2−/− cells as compared with Sesn2+/+ controls (Fig. 7e). 
Similarly diminished uncoupler-stimulated rates were observed on each of the substrates (data not shown). To 
examine the potential impact of Sesn2 on mitochondrial respiration in the conditions of glucose deprivation 
we incubated cells in glucose-free medium for 6 hr and analyzed basal and maximal mitochondrial respiration 
as described above. We found that basal and maximal levels of mitochondrial respiration were significantly 
diminished in Sesn2-deficient MEF as compared to control cells (Fig. 7f,g). However, despite the compromised 
mitochondrial activity, the amounts of mitochondrial DNA were higher in Sesn2-deficient MEF incubated with 
control and glucose-free medium (Fig. 7h) as compared to Sesn2-proficient MEF, indicating that the effects of 
Sesn2-inactivation on mitochondrial activity cannot be simply explained by regulation of mitochondrial content 
by Sesn2. Altogether, we conclude that Sesn2 plays an important role in supporting mitochondrial function that 
can protect cell viability in conditions of nutrient deficiency.
www.nature.com/scientificreports/
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Discussion
Glucose is a significant substrate for ATP production and glycosylation for eukaryotic cells. Glucose deficiency, 
induced by normal processes of tissue growth during embryogenesis or by pathological conditions such as can-
cer, stroke, or infarction, stimulates the UPR1,3. The outcome of UPR activation depends on the severity and 
duration of ER stress: while the acute response potentially mitigates the consequences of ER stress, prolonged 
ER stress eventually stimulates cell death4,5. SESN2 has recently been reported as a protein activated by ER stress 
via ATF4, among the other potential UPR transcriptional factors26,40. NRF2 is also a critical regulator of SESN2 
under various stress conditions25,41. Both of these transcriptional factors directly bind the SESN2 promoter25,26 
and are activated via the same PERK1-dependent branch of the UPR3,7. We have shown here that glucose starva-
tion stimulates SESN2 expression via induction of ER stress and activation of both ATF4 and NRF2 followed by 
their direct binding to the SESN2 promoter. These two transcription factors can interact and cooperate to acti-
vate the transcription of specific genes42,43. Interestingly, these effects were independent of the master regulator 
of SESN2, p53, which is critical for SESN2 activation by DNA damage9,44. Thus, we conclude that there are two 
major mechanisms of SESN2 activation: one via UPR-dependent activation ATF4 and NRF2, and another via 
Figure 6. Glucose starvation-induced cell death is inhibited by Necrostatin 7. (a) Inhibitors of autophagy, 
necroptosis, or ferroptosis do not inhibit cell death induced by glucose starvation. Sesn2+/+ and Sesn2−/− 
MEF were incubated in glucose free medium in the presence of inhibitors of autophagy, 3 MA (2 mM) or 
cloroquine, CQ (50 μM), an inhibitor of RIP1-dependent necroptosis, Necrostatin 1 (10 μg/ml), an inhibitor 
of ferroptosis, Ferrostatin (2 μM), or an inhibitor of ER stress, TUDCA (10μM). Cell death was analyzed by 
PI staining followed by flow cytometry. The data represent a mean of three independent experiments ± S.D. 
Two-way ANOVA followed by linear contrasts with Bonferroni correction (adjusted α = 0.05/16 = 0.003125, 
**P < 0.003125). (b) Cell death induced by glucose starvation is suppressed by Necrostatin 7 in Sesn2−/− cells. 
Sesn2+/+ and Sesn2−/− MEF were incubated with glucose-free medium in the presence or absence of Necrostatin 
7 (5 μg/ml), and the levels of cell death were assessed by PI staining followed by flow cytometry. The data 
represent a mean of three independent experiments ± S.D. Two-way ANOVA with replication, followed by 
Bonferroni post-test (*p < 0.05, **p < 0.01).
www.nature.com/scientificreports/
1 0Scientific RepoRts | 6:22538 | DOI: 10.1038/srep22538
Figure 7. Sesn2 protects cells from cell death induced by glucose starvation via regulation of mitochondrial 
function. (a) Sesn2 supports ATP production in response to glucose starvation. Sesn2+/+ and Sesn2−/− MEF were 
incubated with glucose-free medium and ATP levels were analyzed by an ATP determination kit. The lysates were 
normalized according to protein content and the values represent the concentration of ATP in the lysates. The 
data represent a mean of three independent experiments ± S.D. Two-way ANOVA followed by linear contrasts 
with Bonferroni correction (adjusted α = 0.05/5 = 0.01, **P < 0.01). (b–g) Mitochondrial activity is diminished 
in Sesn2-deficient MEF. Sesn2−/− MEF have decreased proton production rate (b), rate of basal mitochondrial 
respiration (c) and maximal respiration rate in the presence of protonophore FCCP (D) as compared to Sesn2+/+ 
counterparts. (e) Sesn2-deficiency compromises the capacity of mitochondria to oxidize particular respiratory 
substrates including pyruvate, glutamate, or palmitoyl carnitine in the presence of malate (Pyr/Mal, Glu/Mal and 
PalmC/Mal), or succinate in the presence of rotenone (Succ/Rot) in the permeabilized cells. (f,g) Sesn2−/− cells 
have a decreased rate of basal (f) and maximal mitochondrial respiration rate (g) as compared to Sesn2+/+ controls 
in glucose-free medium. (b–g) The results were normalized according to cell number and data presented as a 
mean of 6 biological replicates. The data are presented as mean ± S.D. At least 10 technical replicates (10 wells) 
were conducted for each biological replicate. Two-way t-test (**p < 0.05, ***p < 0.001). (h) Sesn2−/− MEF have 
decreased mtDNA/gDNA ratio as compared to Sesn2+/+ cells. Sesn2+/+ and Sesn2−/− cells were incubated with 
control and glucose free medium and the relative levels of mitochondrial (mtDNA) and genomic DNA (gDNA) 
were examined by qPCR. The data represent a mean of three independent experiments ± S.D. Two-way ANOVA 
followed by linear contrasts with Bonferroni correction (adjusted α = 0.05/7 = 0.007).
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p53 in response to DNA damage. In some stress conditions, such as that imposed by hydrogen peroxide treat-
ment, both mechanisms may cooperate for maximal SESN2 induction12,13. In contrast to previous observations, 
SESN2 neither regulates expression of any UPR proteins, nor the activity of the AMPK-mTOR pathway during 
glucose withdrawal28,29,45. As reported previously, glucose deprivation does not induce autophagic flux30, and 
SESN2 plays no role in regulation of general autophagy under these conditions. As we demonstrated, SESN2 
is a critical regulator of cell viability9,12,24. Accordingly, SESN2 inactivation strongly sensitizes cells to cell death 
induced by glucose starvation. Glucose starvation induces necrotic-like cell death associated with a drop of ATP 
levels, that prevents activation of the classical apoptotic program46. Despite the activation of caspases and pro-
duction of ROS in response to glucose starvation, we did not see any significant role of caspases and ROS in cell 
death under our experimental conditions. Moreover, characterization of cell death by glucose starvation let us to 
rule out the impact of classical RIP1-dependent necroptosis, ferroptosis, and autophagy in cell demise induced 
by glucose starvation and rule out the potential contribution of Sesn2 in these processes. Thus, we presumed that 
Sesn2 regulates a non-canonical necroptotic cell death. Pursuing the potential mechanism of the regulation of cell 
death by Sesn2, we found that Necrostatin 7 suppresses cell death in Sesn2−/− cells, equalizing it with the levels 
of cell death in Sesn2+/+ cells in response to glucose starvation. Necrostatin 7 is a recently described inhibitor of 
RIP1-independent necroptosis38. Thus, we concluded that Sesn2 is involved in protecting cells from necroptosis 
associated with glucose starvation. In agreement with this conclusion, the pro-survival role of Sesn2, we demon-
strated recently that Sesn2 partially protects from necrotic cell death in the heart47. While this manuscript was 
under preparation, another group reported SESN2 as glucose-regulated gene that protects from apoptotic cell 
death in human hepatocarcinoma cells45. However, in contrast to their results, we did not see any role of SESN2 in 
the regulation of caspase-dependent apoptosis induced by glucose starvation, but demonstrated its role in necrop-
tosis. Also, in contrast to their publication, we did not observe any impact of the AMPK-mTORC1 pathway or 
ROS on the regulation of cell viability by Sesn2 in response to glucose starvation. These differences might be 
explained by the involvement of SESN2 in different types of cell death in different cellular contexts. The potential 
mechanism of regulation of cell death by SESN2 in the conditions of energy stress might involve regulation of 
metabolism and ATP production. Mitochondria are critical source of ATP (required for apoptotic cell death) and 
insufficient ATP supply can re-direct cells to necrosis/necroptosis48,49. Accordingly, a drop in ATP levels occurred 
much faster in Sesn2−/− cells as compared to Sesn2+/+ controls. The rate of ATP production on either endogenous 
stored substrates or alternative substrates present in DMEM (including glutamine, pyruvate, and other amino 
acids) may provide fuel necessary for cell survival under glucose starvation. We also observed that both the rate 
of extracellular acidification (proton production rate) and basal and maximal uncoupler-stimulated mitochon-
drial oxygen consumption are lower in the Sesn2−/− fibroblasts under control conditions. Moreover, we observed 
that both basal and maximal levels of mitochondrial respiration were lower in glucose-starved Sesn2−/− cells as 
compared to the control, thus contributing to diminished ATP production. The fact that rates of State 3 (phos-
phorylating) respiration on a variety of oxidizable substrates were all lower in the permeabilized Sesn2-deficient 
cells suggests diminished mitochondrial respiratory capacity in these cells independent of the substrate pathway. 
Together these data strongly suggest a role of Sesn2 in the control of overall cellular energy metabolism and 
maintenance of mitochondrial respiratory capacity. Further, the combination of intact and permeabilized cell 
respiratory data indicate that the mechanism of Sesn2 regulation does not involve selective inhibition of Complex 
I or II activity (Fig. 7e), nor does it specifically inhibit the enzymes and transporters directly involved in ATP 
synthesis, as uncoupler-stimulated respiration was also compromised (Fig. 7d,e). Nevertheless, we did not see a 
physical association of Sesn2 with mitochondria12,20, we and others recently described that SESN2 interacts with 
GATOR221,20,50. Although the precise localization and function of GATOR2 remains unknown, SEACAT, the 
yeast analog of mammalian GATOR2, interacts with mitochondrial proteins and potentially regulates mitochon-
drial function51,52. In future work the role of GATOR2 in the regulation of mitochondrial activity and cell death 
by SESN2 will be explored. Another potential explanation for the role of SESN2 in regulation of mitochondrial 
function is the potential role of SESN2 in control of protein lysosomal degradation. It was demonstrated that 
SESN2 inactivation compromises lysosomal degradation of PDGFRβ and XIAP proteins53,54. Thus, the impact of 
SESN2 on the regulation of mitochondrial function and suppression of necroptosis might be mediated by control 
of degradation by a yet-to-be identified protein involved in the regulation of mitochondrial metabolism.
Necrosis/necroptosis contributes to the pathogenesis of many human diseases such as ischemic stroke, trau-
matic brain injury, neurodegenerative disorders and cancer55. Pharmacological modulation of SESN2 activity 
can be a powerful tool to prevent necrotic cell death under different pathological conditions and mitigate conse-
quences of the diseases.
Materials and Methods
Cell culture, transfection, infection and treatment. Immortalized Sesn2+/+ and Sesn2−/− MEF, 
and human lung adenocarcinoma H1299 and H460 cell lines were cultured in high-glucose DMEM contain-
ing 10% FBS and penicillin/streptomycin. H1299 cells were infected with sgCtrl.- or sgSESN2-bearing lentivi-
ruses and selected with puromycin for two weeks to obtain stable Sesn2-deficient cell lines. H1299-tet-off-p53 
cells were previously described9. All transfections were performed with Lipofectamine and Plus reagents (Life 
Technologies) and infections with lentiviral vectors were performed as previously described14. The treatments 
with glucose-free medium, 2-deoxyglucose, rotenone, Aicar, tunicamycin, N-acethyl-cysteine, Boc-D-FMK, 
rapamycin, 3-Methyladenine, chloroquine, Necrostatin 1, Ferrostatin 1, TUDCA, Necrostatin 7, were performed 
for 24 hr unless otherwise specified.
Cell lysis and immunoblot analyses. Cells were lysed in RIPA-SDS buffer, after which the proteins were 
resolved by SDS-PAGE, transferred onto PVDF membranes, and probed with the relevant antibodies as pre-
viously described9. The following antibodies were used for the experiments: anti-actin (Sigma); anti-SESN2 
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(Proteintech), anti-NRF2, anti-CHOP and anti-p53 (Santa Cruz); and anti-phospho(T389)-p70S6K, 
a n t i - p h o s p h o ( S 2 3 5 / 2 3 6 ) - S 6 ,  a n t i - p h o s p h o ( S 6 5 ) - 4 E - B P 1 ,  a n t i - p h o s p h o  I F 2α  ( S 5 1 ) , 
anti-phospho(T172)-AMPKα , anti-phospho(S79)-acetyl-CoA carboxylase, anti-phospho(S9)-GSK3β , 
anti-phospho(T1462), anti-4E-BP1, anti-S6, anti-TSC2, anti-AMPKα , anti-ATF4, anti-Bip, anti-p62, anti-LC3, 
anti-PARP, anti-PARP(cleaved), anti-caspase3, and anti-caspase3(cleaved) (Cell Signaling Inc). Sesn1 antibodies 
were previously described11.
Constructs. Reconstitution experiment was performed with pBabe-hygro Sesn2 (mouse) con-
struct. The sequence for shSesn2 is 5 ′- GAAGACCCTACTTTCGGAT-3 ′  and for sgSesn2 is 
5′-CTCGGAGTCCGCCACGATCA-3′ . The shNRF2 and shATF4 were previously described29,56. 
The primers used for qPCR were as fol lows: SESN1: 5 ′  -GCATGTTCCAACATTTCGTG-3 ′ 
and 5-TCCCACATCTGGATAAAGGC-3 ′ ;  SESN2: 5 ′-GACCATGGCTACTCGCTGAT-3 ′   and 
5 ′-GCTGCCTGGAACTTCTCATC-3 ′ ;  and SESN3: 5 ′-ATGCTTTGGCAAGCTTTGTT-3 ′   and 
5′-GCAAGATCACAAACGCAGAA-3′.
Cell death analysis. Cells were treated, harvested and washed in PBS. Pellets were re-suspended in Annexin 
V binding buffer and incubated with anti-Annexin V FITC antibody and propidium iodide (PI) following the 
manufacturer’s instructions (BD Biosciences). Cells were acquired on a BD FACSCalibur instrument and data 
were analyzed with FCS Express 4 software (De Novo Software).
ROS examination. To examine ROS levels, cells were incubated with DCF-DA for 30 minutes (Life Science) 
and analyzed by flow cytometry.
ATP determination. ATP levels were examined with an ATP determination kit (Life Technologies A22066) 
according to manufacturer protocol. The cellular lysates were normalized to protein concentration and ATP con-
centration in the solution was measured per amount of lysate containing 1 μg of protein.
Real Time PCR. RNA was isolated from Trizol-lysed cells and reverse-transcribed using Quanta Biosciences 
cDNA Synthesis kit. cDNA, primers, and SYBRGreen master mix (BioRad) were mixed and run on a Stratagene 
MX3000 instrument. Ct values were normalized using two housekeeping genes.
Chromatin immunoprecipitation analysis (CHIP). H1299 cells were cultured in regular medium or in 
glucose-free medium for the indicated time points, cross-linked with 1% paraformaldehyde, and harvested. Cells 
were then lysed and protein-chromatin extracts were obtained and digested using the Cell Signaling Technology 
ChIP kit (catalog # cs-9005) as per the manufacturer’ s instructions. ChIP grade Abs for anti-histone H3 (cs-
4620), anti-NRF2 (cs-12721), anti-ATF4 (cs-11815), or normal rabbit IgG (cs-2729) were incubated over night 
with the cell extracts. Magnetic beads were then added and protein-chromatin-Ab immune complexes were pre-
cipitated. After reversing the cross-links, DNA was purified and targets were amplified by real time PCR using the 
following sets of primers specific for human SESN2 promoter: NRF2: 5′ -CAATAGGGATTGAGGTTCCAC-3′ 
and 5′ -ACAGGGAATTCACCTTATTTGT-3′ 25; ATF4 distal: 5′ -GATCCAATTGGCTGACTTTG-3′ and 
5′ -ACTAACACATTTGCTTGTTCAC-3′ ; and ATF4 proximal: 5′ -ATGACTCTTAGGGCTGTCA-3′ and 
5′ -GGAATTCTGGGAGTTGTAGTC-3′ 26. The amount of immunoprecipitated DNA in each sample is repre-
sented as signal relative to the total amount of input chromatin.
Analysis of Mitochondrial Respiration and Extracellular Acidification. Sesn2+/+ and Sesn2−/− MEF 
were plated in XF96 plates at 2 × 104 cells/well for 24 hr growth or at 1.25 × 104 cells/well for 48 hr growth. On the 
day of the assay, growth medium was exchanged for bicarbonate-free DMEM (Sigma #5030) supplemented with 
10 mM glucose, 3 mM glutamine, 1 mM pyruvate, and 2 mM HEPES. Rates of mitochondrial and maximal respi-
ration in intact cells were measured and defined as previously reported39. Proton production rates were calculated 
after determining the medium buffering capacity for the 2.28 μL measurement chamber according to Mookerjee 
et al.57. State 3 respiration rates in permeabilized cells were measured using recombinant perfringolysin O (com-
mercially XF PMP)58. Concentrations and protocols are given in Divakaruni et al.59. Oxygen consumption and 
proton production rates were normalized to relative cell number by post-hoc nuclear staining with CyQuant 
(ThermoFisher). In general, the nuclei counts across each cell type did not vary more than + /− 5%. To analyze 
cell respiration in glucose-starved cells, the cells were incubated with glucose free medium for 6 hr, and examined 
by Seahorse analysis in the glucose-free assay medium containing 1 mM pyruvate and 2 mM glutamine.
Quantification of mitochondrial:genomic DNA ratio. MEF were cultured in the indicated conditions, 
washed twice with ice-cold PBS, and then lysed in 500 μl of lysis buffer (10 mM Tris pH8.0, 100 mM NaCl, 10 mM 
EDTA, 0.5% SDS, 100 μg/ml proteinase K) overnight at 55 °C. Next, 50 μl of 3 M sodium acetate was added to the 
tubes and mixed. DNA was precipitated by adding 500 μl/tube of 100% isopropanol, followed by a 2 hr incubation 
at − 20 °C. DNA was pelleted by centrifuging samples at maximum speed in a microfuge for 20 minutes and was 
then washed twice in 70% ethanol. DNA was dissolved in 50–100 μl of H2O and its concentration was established 
using a NanoDrop 1000 spectrophotometer (ThermoScientific).
For real time PCR, 15 ng of DNA per reaction were amplified using the following primers - for mitochon-
drial DNA: Cytb F: GGAACAACCCTAGTCGAATG, Cytb R: AGGGCCGCGATAATAAATG; for genomic 
DNA: B2m F: CCTTAAGTCAAGGTGGTTATGA, B2 m R: GACTTTGGTAGTTACTAGTTATCCT. Ct val-
ues obtained at the end of the PCR were used to determine the relative mtDNA:gDNA ratio in each sample. 
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mtDNA:gDNA ratio from the WT, untreated control was set as 1 and ratios from the other samples were then 
normalized to it.
Statistical analysis. Statistical analysis was performed using two-sample t-test. For experiments involving 
more than two factors, a one-way or two-way ANOVA model was fit followed by linear contrasts to compare 
groups of interest and multiple comparisons were adjusted using the Bonferroni method. Statistical significance 
was defined as p < 0.05. Results are presented as mean ± standard deviation (± S.D.) of at least three independent 
experiments.
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